Literature DB >> 22029682

A case of multicentric Castleman's disease with membranoproliferative glomerulonephritis type 3-like lesion.

Kei Nagai1, Joichi Usui, Kazuyuki Noguchi, Kei Unai, Akira Hiwatashi, Yoh Arakawa, Amane Togashi, Naoki Morito, Chie Saito, Keigyou Yoh, Syuichi Tsuruoka, Hiroshi Kojima, Kumi Aita, Michio Nagata, Kunihiro Yamagata.   

Abstract

Renal involvement is a significant complication of multicentric Castleman's disease (MCD) and various glomerular involvements have been reported. A 45-year-old Japanese man presented with persistent proteinuria, with lymphadenopathy and hypergammaglobulinemia. He had been diagnosed 4 years previously with MCD. As his renal impairment had progressed to renal failure, he underwent a renal biopsy. Histology revealed diffuse and global membranous lesions with large and heterogeneous epimembranous deposits. In addition, mesangial cell proliferation and focal extracapillary lesions were found. Under immunofluorescence, granular staining for anti-IgG, IgG1, IgG2 and IgA was strongly positive in the capillary loop, and weakly positive in the mesangium. As such, there was a diversity of histological features. Our perspective with regard to pathogenesis is that the formation of the immune-complex contributed to the membranoproliferative glomerulonephritis type 3-like lesion. This histological multiform with MCD is valuable for increasing our understanding of the mechanism for onset of immune-complex glomerular deposition and cellular proliferation of glomerulonephritis.
© 2011 The Authors. Pathology International © 2011 Japanese Society of Pathology and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22029682     DOI: 10.1111/j.1440-1827.2011.02727.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  Multicentric Castleman's disease with renal amyloidosis and mesangial proliferative glomerulonephritis: a case report.

Authors:  Zhicheng Tan; Lihua Wang; Chen Wang; Lifang Gao; Yanrong Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Efficacy of tocilizumab, a humanized neutralizing antibody against interleukin-6 receptor, in progressive renal injury associated with Castleman's disease.

Authors:  Akito Maeshima; Masao Nakasatomi; Daizo Henmi; Shin Yamashita; Yoriaki Kaneko; Takashi Kuroiwa; Keiju Hiromura; Yoshihisa Nojima
Journal:  CEN Case Rep       Date:  2012-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.